Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has analysts on the Bullish side this week.

Investors sentiment decreased to 1.09 in Q2 2019. Its down 0.49, from 1.58 in 2019Q1. It is negative, as 29 investors sold Acadia Healthcare Company, Inc. shares while 57 reduced holdings. 24 funds opened positions while 70 raised stakes. 98.51 million shares or 3.50% less from 102.09 million shares in 2019Q1 were reported.
Skyline Asset Mngmt Lp has 1.5% invested in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) for 236,300 shares. 294,548 were reported by Ameriprise Fincl. 1,500 were accumulated by Benjamin F Edwards Inc. Ing Groep Nv reported 0.02% stake. Putnam Invs Ltd holds 0.01% of its portfolio in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) for 65,633 shares. 145,361 are held by Mondrian Invest Prtnrs Limited. Utd Automobile Association has invested 0.01% of its portfolio in Acadia Healthcare Company, Inc. (NASDAQ:ACHC). Raymond James Service Advisors Inc has invested 0% in Acadia Healthcare Company, Inc. (NASDAQ:ACHC). Signaturefd Ltd Company reported 0% of its portfolio in Acadia Healthcare Company, Inc. (NASDAQ:ACHC). Thompson Mngmt Incorporated stated it has 15,660 shares or 0.11% of all its holdings. Retirement Systems Of Alabama reported 115,373 shares. Fir Tree Mgmt Ltd Partnership reported 594,500 shares. Citadel Advsr Limited Liability has 0% invested in Acadia Healthcare Company, Inc. (NASDAQ:ACHC). Palisade Capital Ltd Com Nj stated it has 0.55% of its portfolio in Acadia Healthcare Company, Inc. (NASDAQ:ACHC). Stephens Ar, Arkansas-based fund reported 9,946 shares.

Since September 5, 2019, it had 1 insider purchase, and 0 insider sales for $530,660 activity.

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Ratings Coverage

Among 2 analysts covering Acadia Healthcare (NASDAQ:ACHC), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. Acadia Healthcare has $45 highest and $2900 lowest target. $35.67’s average target is 11.47% above currents $32 stock price. Acadia Healthcare had 5 analyst reports since March 21, 2019 according to SRatingsIntel. The stock of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) earned “Outperform” rating by Raymond James on Wednesday, July 31. UBS maintained the stock with “Neutral” rating in Friday, September 6 report. The company was maintained on Thursday, June 20 by Raymond James. Below is a list of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) latest ratings and price target changes.

06/09/2019 Broker: UBS Rating: Neutral Old Target: $30.0000 New Target: $29.0000 Maintain
31/07/2019 Broker: Raymond James Old Rating: Strong Buy New Rating: Outperform New Target: $45.0000 Downgrade
20/06/2019 Broker: Raymond James Rating: Buy New Target: $45 Maintain
01/05/2019 Broker: Inc. – Common Stock Rating: Bmo Capital New Target: $33.0000 36.0000
21/03/2019 Broker: BidaskScore Rating: Sell Upgrade

The stock increased 1.33% or $0.42 during the last trading session, reaching $32. About 536,978 shares traded. Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has declined 25.89% since September 13, 2018 and is downtrending. It has underperformed by 25.89% the S&P500.

Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States, the United Kingdom, and Puerto Rico. The company has market cap of $2.83 billion. The companyÂ’s acute inpatient psychiatric facilities offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities include residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs. It currently has negative earnings. It also provides outpatient community services, such as community programs that are designed to provide therapeutic treatment to children and adolescents who have a clinically-defined emotional, psychiatric, or chemical dependency disorder.

More notable recent Acadia Healthcare Company, Inc. (NASDAQ:ACHC) news were published by: Nasdaq.com which released: “Acadia Healthcare (ACHC) Surpasses Q2 Earnings Estimates – Nasdaq” on July 30, 2019, also Globenewswire.com with their article: “ACADIA HEALTHCARE ANNOUNCES DATE FOR SECOND QUARTER 2019 EARNINGS RELEASE – GlobeNewswire” published on July 18, 2019, Nasdaq.com published: “Acadia Healthcare Company Enters Oversold Territory (ACHC) – Nasdaq” on August 01, 2019. More interesting news about Acadia Healthcare Company, Inc. (NASDAQ:ACHC) were released by: Finance.Yahoo.com and their article: “Is Acadia Healthcare Company Inc (ACHC) A Good Stock To Buy? – Yahoo Finance” published on June 19, 2019 as well as Seekingalpha.com‘s news article titled: “Acadia’s president bids adieu – Seeking Alpha” with publication date: March 26, 2019.

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.